gadolinium has been researched along with Acute Confusional Senile Dementia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Åslund, AKO; Bäck, M; Davies, CL; Hammarström, P; Nilsson, KPR; Nilsson, LNG; Sulheim, E; WiderØe, M | 1 |
| Bolze, F; Chan, HN; Desbois, N; Gros, CP; Li, HW; Li, Y; Wang, X; Wong, MS | 1 |
| Allémann, E; Dumoulin, M; Forge, V; Heinrich-Balard, L; Lux, F; Marquette, C; Morfin, JF; Pansieri, J; Plissonneau, M; Rivory, P; Saraiva, MJ; Stransky-Heilkron, N; Tillement, O; Toth, E | 1 |
| Arrighi, HM; Barakos, J; Black, R; Brashear, HR; Fiebach, JB; Gass, A; Grundman, M; Jack, C; Lu, Y; Melançon, D; Miaux, Y; Morris, KA; Rippon, G; Salloway, S; Sperling, R; Tampieri, D | 1 |
| Essig, M; Gerigk, L; Hauser, T; Henze, R; Radbruch, A; Schönknecht, P; Schröder, J; Thomann, PA | 1 |
| Ballet, S; Borderies, H; Bort, G; Catoen, S; Ferroud, C; Kebsi, A; Louin, G; Port, M | 1 |
| Allen, MJ; Kochi, A; Lee, HJ; Lim, MH; Padmini, V; Vithanarachchi, SM | 1 |
| Austen, B; Howe, F; Matharu, B; Spencer, N | 1 |
| Allémann, É; Cohen, R; Dumoulin, M; Forge, V; Heinrich-Balard, L; Louis, C; Lux, F; Marquette, C; Morfin, JF; Mowat, P; Pansieri, J; Plissonneau, M; Rivory, P; Saraiva, MJ; Stransky-Heilkron, N; Tillement, O; Tόth, É | 1 |
| Bard, F; Blockx, I; Einstein, S; Guglielmetti, C; Guns, PJ; Roose, D; Van Audekerke, J; Van der Linden, A; Verhoye, M; Zago, W | 1 |
| Amatsubo, T; Morikawa, S; Taguchi, H; Tooyama, I; Yanagisawa, D | 1 |
| Benavides, J; Bertrand, A; Debeir, T; Dhenain, M; Hantraye, P; Houitte, D; Petiet, A; Petit, F; Rooney, T; Santin, M; Wiggins, CJ | 1 |
| Farrar, CT; Hyman, BT; Koffie, RM; Saidi, LJ; Spires-Jones, TL; William, CM | 1 |
| Allen, MJ; Vithanarachchi, SM | 1 |
| Borowski, BJ; Curran, GL; Jack, CR; Macura, SI; Poduslo, JF; Sigurdsson, EM; Wengenack, TM; Wisniewski, T | 1 |
| Asuni, A; Blind, JA; de Leon, MJ; Knudsen, E; Li, Y; Mosconi, L; Sadowski, M; Scholtzova, H; Sigurdsson, EM; Tsui, WH; Turnbull, DH; Wadghiri, YZ; Wisniewski, T | 1 |
| Curran, GL; Gilles, EJ; Kandimalla, KK; Poduslo, JF; Wengenack, TM | 1 |
| English, CD; Harris, GJ; Lewis, RF; Renshaw, PF; Satlin, A; Scott, TM; Yurgelun-Todd, DA | 1 |
2 review(s) available for gadolinium and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
MR imaging features of amyloid-related imaging abnormalities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Antibodies, Monoclonal, Humanized; Brain; Brain Edema; Cerebral Hemorrhage; Clinical Trials, Phase II as Topic; Gadolinium; Hemosiderin; Humans; Incidence; Magnetic Resonance Imaging; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index | 2013 |
Amyloid imaging using high-field magnetic resonance.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cell Tracking; Contrast Media; Fluorine Radioisotopes; Gadolinium; Humans; Magnetic Resonance Imaging; Plaque, Amyloid | 2010 |
16 other study(ies) available for gadolinium and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Contrast Enhanced Magnetic Resonance Imaging of Amyloid-β Plaques in a Murine Alzheimer's Disease Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Plaque, Amyloid | 2023 |
Multimodal Theranostic Cyanine-Conjugated Gadolinium(III) Complex for
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Carbocyanines; Coordination Complexes; Disease Models, Animal; Gadolinium; Magnetic Resonance Imaging; Mice | 2021 |
Multimodal imaging Gd-nanoparticles functionalized with Pittsburgh compound B or a nanobody for amyloid plaques targeting.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Diabetes Mellitus, Type 2; Gadolinium; Humans; Immunohistochemistry; Islet Amyloid Polypeptide; Mice; Multimodal Imaging; Nanoparticles; Plaque, Amyloid; Single-Domain Antibodies; Thiazoles | 2017 |
Regional cerebral perfusion alterations in patients with mild cognitive impairment and Alzheimer disease using dynamic susceptibility contrast MRI.
Topics: Aged; Alzheimer Disease; Blood Flow Velocity; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Cognitive Dysfunction; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Angiography; Male; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Gadolinium-based contrast agents targeted to amyloid aggregates for the early diagnosis of Alzheimer's disease by MRI.
Topics: Alzheimer Disease; Animals; Contrast Media; Early Diagnosis; Gadolinium; Humans; Mice; Plaque, Amyloid; Radionuclide Imaging | 2014 |
Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Capillary Permeability; Cell Line, Tumor; Cell Survival; Copper; Curcumin; Gadolinium; Mice; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Zinc | 2015 |
Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease.
Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biosensing Techniques; Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Young Adult | 2015 |
Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Female; Gadolinium; Gene Expression; Hippocampus; Humans; Kinetics; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Mice, Transgenic; Mutation; Peptide Fragments; Peptides; Plaque, Amyloid; Prealbumin; Protein Binding; Surface Plasmon Resonance | 2016 |
Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blood-Brain Barrier; Disease Models, Animal; Female; Gadolinium; Immunotherapy; Magnetic Resonance Imaging; Mice; Mice, Transgenic | 2016 |
Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
Topics: Alzheimer Disease; Animals; Brain; Contrast Media; Female; Gadolinium; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Molecular Imaging; Plaque, Amyloid; Staining and Labeling; Tissue Distribution | 2012 |
Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging.
Topics: Alkaloids; Alzheimer Disease; Animals; Apolipoproteins E; Blood-Brain Barrier; Brain; Contrast Media; Gadolinium; Indoles; Magnetic Resonance Imaging; Mice; Nanoparticles; Optics and Photonics; Photons; Quinolines; Trypan Blue | 2011 |
A multimodal, β-amyloid-targeted contrast agent.
Topics: Alzheimer Disease; Amyloid; Contrast Media; Coordination Complexes; Fluorescent Dyes; Gadolinium; Humans; Magnetic Resonance Imaging; Radiography | 2013 |
Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzothiazoles; Binding, Competitive; Blood-Brain Barrier; Brain; Contrast Media; Disease Models, Animal; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Membrane Proteins; Mice; Mice, Transgenic; Molecular Probe Techniques; Neurons; Peptide Fragments; Plaque, Amyloid; Predictive Value of Tests; Presenilin-1; Putrescine; Reproducibility of Results; Thiazoles | 2002 |
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Contrast Media; Disease Models, Animal; Gadolinium; Ligands; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Molecular Probe Techniques; Peptide Fragments; Plaque, Amyloid | 2008 |
Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cerebral Cortex; Contrast Media; Gadolinium; Hippocampus; Humans; Kinetics; Magnetic Resonance Imaging; Mice; Mice, Inbred Strains; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Presenilin-1 | 2007 |
Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Blood Volume; Cerebrovascular Circulation; Diagnosis, Differential; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Male; Organometallic Compounds | 1996 |